Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rishi P Verma"'
Autor:
Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P. Verma, Bianca Chun, Kelly D. Johnson, Nicole Cossrow, M. Doyinsola Bailey, Thomas Weiss, Elmira Flem, Jordana K. Schmier
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 966-973 (2024)
Objectives It is important to assess healthcare providers (HCPs) knowledge, attitudes, perceptions, and preferences towards new pneumococcal vaccines for adults.Methods HCPs who met eligibility criteria completed an online survey between March – Ma
Externí odkaz:
https://doaj.org/article/c1780d314f504aaa9d00291946954888
Autor:
Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P. Verma, Marieke Heisen, Jessica Weaver, Kristen A. Feemster, Bianca Chun, Thomas W. Weiss, Jordana K Schmier
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTAs higher-valent pneumococcal conjugate vaccines (PCVs) become available for pediatric populations in the US, it is important to understand healthcare provider (HCP) preferences for and acceptability of PCVs. US HCPs (pediatricians, family me
Externí odkaz:
https://doaj.org/article/00e26ba049014e4383bf9cb8bf3d7a56
Autor:
Priti Prasad, Uzma Khatoon, Rishi Kumar Verma, Shahre Aalam, Ajay Kumar, Debashish Mohapatra, Parthasarthi Bhattacharya, Sumit K. Bag, Samir V. Sawant
Publikováno v:
Frontiers in Plant Science, Vol 13 (2022)
Cotton fiber development is still an intriguing question to understand fiber commitment and development. At different fiber developmental stages, many genes change their expression pattern and have a pivotal role in fiber quality and yield. Recently,
Externí odkaz:
https://doaj.org/article/c662096d99794a92a32beb707551f520
Autor:
Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Pena-Molina, Rishi P Verma, Marieke Heisen, Jessica Weaver, Kristen A Feemster, Thomas Weiss, Jordana Schmier
Publikováno v:
Open Forum Infectious Diseases. 9
Background As higher-valent PCVs are currently in late-stage clinical development for pediatric use, it is important to understand how healthcare providers (HCPs) evaluate vaccine attributes when making recommendations for newer PCVs. The Advisory Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba41831a33d0797723a1a9ba42ec324b
https://doi.org/10.1093/ofid/ofac492.635
https://doi.org/10.1093/ofid/ofac492.635
Autor:
Vimalanand S. Prabhu, Sneha S. Kelkar, Jingchuan Zhang, Yao Qiao, Rishi P. Verma, Jordana Schmier, Nicola Miles, Jenny King, Christian Marth
Publikováno v:
Journal of Clinical Oncology. 40:e17627-e17627
e17627 Background: Until recently, recurrent or advanced endometrial cancer (aEC) patients in Europe had limited treatment options, with no consensus on standard of care in such settings. Approval of novel targeted therapies in 2021 are changing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62ac0d7f49f5ab25405aa0d12c2558b2
https://doi.org/10.1200/jco.2022.40.16_suppl.e17627
https://doi.org/10.1200/jco.2022.40.16_suppl.e17627